Beasley DWC - Search Results

1

Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2.

Thursz M, Sadiq F, Tree JA, Karayiannis P, Beasley DWC, Dejnirattisai W, Mongkolsapaya J, Screaton G, Wand M, Elmore MJ, Carroll MW, Matthews I, Thomas H. Thursz M, et al. Among authors: beasley dwc. J Gen Virol. 2023 Jul;104(7). doi: 10.1099/jgv.0.001865. J Gen Virol. 2023. PMID: 37432877

2

Genetic variation in the 3' non-coding region of dengue viruses.

Shurtleff AC, Beasley DW, Chen JJ, Ni H, Suderman MT, Wang H, Xu R, Wang E, Weaver SC, Watts DM, Russell KL, Barrett AD. Shurtleff AC, et al. Virology. 2001 Mar 1;281(1):75-87. doi: 10.1006/viro.2000.0748. Virology. 2001. PMID: 11222098 Free article.

3

Emergence of attenuated West Nile virus variants in Texas, 2003.

Davis CT, Beasley DW, Guzman H, Siirin M, Parsons RE, Tesh RB, Barrett AD. Davis CT, et al. Virology. 2004 Dec 5;330(1):342-50. doi: 10.1016/j.virol.2004.09.016. Virology. 2004. PMID: 15527859 Free article.

4

A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice.

Wicker JA, Whiteman MC, Beasley DW, Davis CT, Zhang S, Schneider BS, Higgs S, Kinney RM, Barrett AD. Wicker JA, et al. Virology. 2006 Jun 5;349(2):245-53. doi: 10.1016/j.virol.2006.03.007. Epub 2006 Apr 19. Virology. 2006. PMID: 16624366 Free article.

5

Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III.

Zhang S, Bovshik EI, Maillard R, Gromowski GD, Volk DE, Schein CH, Huang CY, Gorenstein DG, Lee JC, Barrett AD, Beasley DW. Zhang S, et al. Virology. 2010 Jul 20;403(1):85-91. doi: 10.1016/j.virol.2010.03.038. Epub 2010 May 6. Virology. 2010. PMID: 20447672 Free PMC article.

6

Molecular evolution of lineage 2 West Nile virus.

McMullen AR, Albayrak H, May FJ, Davis CT, Beasley DWC, Barrett ADT. McMullen AR, et al. Among authors: beasley dwc. J Gen Virol. 2013 Feb;94(Pt 2):318-325. doi: 10.1099/vir.0.046888-0. Epub 2012 Nov 7. J Gen Virol. 2013. PMID: 23136360 Free PMC article.

7

Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.

McAuley AJ, Torres M, Plante JA, Huang CY, Bente DA, Beasley DWC. McAuley AJ, et al. Among authors: beasley dwc. J Virol. 2016 Apr 14;90(9):4757-4770. doi: 10.1128/JVI.02861-15. Print 2016 May. J Virol. 2016. PMID: 26912625 Free PMC article.

8

Corrigendum: Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2.

Thursz M, Sadiq F, Tree JA, Karayiannis P, Beasley DWC, Dejnirattisai W, Mongkolsapaya J, Screaton G, Wand M, Elmore MJ, Carroll MW, Matthews I, Thomas H. Thursz M, et al. Among authors: beasley dwc. J Gen Virol. 2023 Jul;104(7). doi: 10.1099/jgv.0.001876. J Gen Virol. 2023. PMID: 37493135 No abstract available.

9

Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype.

Beasley DW, Li L, Suderman MT, Barrett AD. Beasley DW, et al. Virology. 2002 Apr 25;296(1):17-23. doi: 10.1006/viro.2002.1372. Virology. 2002. PMID: 12036314 Free article.

10

Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein.

Beasley DW, Barrett AD. Beasley DW, et al. J Virol. 2002 Dec;76(24):13097-100. doi: 10.1128/jvi.76.24.13097-13100.2002. J Virol. 2002. PMID: 12438639 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page